Cargando…
A Gene Expression Signature Predicts Bladder Cancer Cell Line Sensitivity to EGFR Inhibition
BACKGROUND: Bladder cancer remains a cancer type in need of novel and alternative therapies. While multiple inhibitors of EGFR have been evaluated for efficacy in bladder cancer, the results have largely been disappointing with few patients responding to these therapies. Yet, there is a subset of pa...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
IOS Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087449/ https://www.ncbi.nlm.nih.gov/pubmed/30112438 http://dx.doi.org/10.3233/BLC-170161 |